These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2328562)

  • 1. Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis.
    Stewart CF; Fleming RA; Arkin CR; Evans WE
    Clin Pharmacol Ther; 1990 Apr; 47(4):540-6. PubMed ID: 2328562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin alters methotrexate disposition in rheumatoid arthritis patients.
    Stewart CF; Fleming RA; Germain BF; Seleznick MJ; Evans WE
    Arthritis Rheum; 1991 Dec; 34(12):1514-20. PubMed ID: 1747136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coadministration of lansoprazole and naproxen does not affect the pharmacokinetic profile of methotrexate in adult patients with rheumatoid arthritis.
    Vakily M; Amer F; Kukulka MJ; Andhivarothai N
    J Clin Pharmacol; 2005 Oct; 45(10):1179-86. PubMed ID: 16172183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis.
    Tracy TS; Krohn K; Jones DR; Bradley JD; Hall SD; Brater DC
    Eur J Clin Pharmacol; 1992; 42(2):121-5. PubMed ID: 1618240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate kinetics in rheumatoid arthritis: is there an interaction with nonsteroidal antiinflammatory drugs?
    Ahern M; Booth J; Loxton A; McCarthy P; Meffin P; Kevat S
    J Rheumatol; 1988 Sep; 15(9):1356-60. PubMed ID: 3199396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of etodolac on methotrexate pharmacokinetics in patients with rheumatoid arthritis.
    Anaya JM; Fabre D; Bressolle F; Bologna C; Alric R; Cocciglio M; Dropsy R; Sany J
    J Rheumatol; 1994 Feb; 21(2):203-8. PubMed ID: 8182625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate disposition following concomitant administration of ketoprofen, piroxicam and flurbiprofen in patients with rheumatoid arthritis.
    Tracy TS; Worster T; Bradley JD; Greene PK; Brater DC
    Br J Clin Pharmacol; 1994 May; 37(5):453-6. PubMed ID: 8054251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate.
    Carmichael SJ; Beal J; Day RO; Tett SE
    J Rheumatol; 2002 Oct; 29(10):2077-83. PubMed ID: 12375315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate serum binding in rheumatoid arthritis.
    Claudepierre P; Urien S; Chevalier X; Chassany O; Larget-Piet B; Tillement JP
    Int J Clin Pharmacol Ther; 1994 Mar; 32(3):113-5. PubMed ID: 8205370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The population pharmacokinetics of long-term methotrexate in rheumatoid arthritis.
    Godfrey C; Sweeney K; Miller K; Hamilton R; Kremer J
    Br J Clin Pharmacol; 1998 Oct; 46(4):369-76. PubMed ID: 9803986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis.
    Bannwarth B; Péhourcq F; Schaeverbeke T; Dehais J
    Clin Pharmacokinet; 1996 Mar; 30(3):194-210. PubMed ID: 8882301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of interaction between bromfenac and methotrexate in patients with rheumatoid arthritis.
    Gumbhir-Shah K; Cevallos WH; DeCleene SA; Korth-Bradley JM
    J Rheumatol; 1996 Jun; 23(6):984-9. PubMed ID: 8782127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of food on the bioavailability of low-dose methotrexate in patients with rheumatoid arthritis.
    Oguey D; Kölliker F; Gerber NJ; Reichen J
    Arthritis Rheum; 1992 Jun; 35(6):611-4. PubMed ID: 1599518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal interaction between methotrexate and naproxen.
    Singh RR; Malaviya AN; Pandey JN; Guleria JS
    Lancet; 1986 Jun; 1(8494):1390. PubMed ID: 2872507
    [No Abstract]   [Full Text] [Related]  

  • 15. Pilot investigation of naproxen/methotrexate interaction in patients with juvenile rheumatoid arthritis.
    Wallace CA; Smith AL; Sherry DD
    J Rheumatol; 1993 Oct; 20(10):1764-8. PubMed ID: 8295192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examination of pharmacokinetic variables in a cohort of patients with rheumatoid arthritis beginning therapy with methotrexate compared with a cohort receiving the drug for a mean of 81 months.
    Kremer JM; Petrillo GF; Hamilton RA
    J Rheumatol; 1995 Jan; 22(1):41-4. PubMed ID: 7699679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of low-dose methotrexate in rheumatoid arthritis patients.
    Herman RA; Veng-Pedersen P; Hoffman J; Koehnke R; Furst DE
    J Pharm Sci; 1989 Feb; 78(2):165-71. PubMed ID: 2715941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations of salicylate and naproxen during concurrent therapy in patients with rheumatoid arthritis.
    Furst DE; Sarkissian E; Blocka K; Cassell S; Dromgoole S; Harris ER; Hirschberg JM; Josephson N; Paulus HE
    Arthritis Rheum; 1987 Oct; 30(10):1157-61. PubMed ID: 3675660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy.
    Kremer JM; Petrillo GF; Hamilton RA
    J Rheumatol; 1995 Jan; 22(1):38-40. PubMed ID: 7699678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.